Dianthus Therapeutics (DNTH) EPS (Basic) (2017 - 2025)
Dianthus Therapeutics' (DNTH) quarterly EPS (Basic) came in at -$4.37 in Q3 2025, down 100.88% year-on-year from $495.51 in Q3 2024, and down 209.57% quarter-over-quarter from -$1.41 in Q2 2025.
Dianthus Therapeutics (DNTH) EPS (Basic) (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$4.37 for Q3 2025.
- On a quarterly basis, EPS (Basic) fell 100.88% year-over-year to -$4.37 in Q3 2025; TTM through Dec 2025 was -$6.95, a 27.37% decrease from a year earlier, with the FY2024 full-year figure at -$7.99, up 75.99% from the prior year.
- EPS (Basic) declined to -$4.37 in Q3 2025 per DNTH's latest filing, from -$1.41 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.7 in Q1 2024 and bottomed at -$8.69 in Q1 2022.
- The 5-year median for EPS (Basic) is -$3.1 (2023), against an average of -$4.28.
- Across the five-year window, EPS (Basic) surged 78.47% in 2023 and plunged 100.88% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$8.17 in 2021, then jumped by 66.83% to -$2.71 in 2022, then slipped by 7.93% to -$2.92 in 2023, then soared by 75.01% to -$0.73 in 2024, then sank by 498.01% to -$4.37 in 2025.
- Per Business Quant, the three latest DNTH EPS (Basic) figures stand at -$4.37 (Q3 2025), -$1.41 (Q2 2025), and -$1.31 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.37 |
| Jun 30, 2025 | -1.41 |
| Mar 31, 2025 | -1.31 |
| Dec 31, 2024 | -0.73 |
| Sep 30, 2024 | -2.18 |
| Jun 30, 2024 | -1.90 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -2.92 |
| Sep 30, 2023 | -5.76 |
| Jun 30, 2023 | -3.10 |
| Mar 31, 2023 | -1.87 |
| Dec 31, 2022 | -2.71 |
| Sep 30, 2022 | -5.02 |
| Jun 30, 2022 | -8.12 |
| Mar 31, 2022 | -8.69 |
| Dec 31, 2021 | -8.17 |
| Sep 30, 2021 | -6.50 |
| Jun 30, 2021 | -7.36 |
| Mar 31, 2021 | -8.49 |
| Dec 31, 2020 | -33.78 |